Trending: AstraZeneca's Rising 1Q Profit Beat Expectations
27 Abril 2023 - 07:36AM
Dow Jones News
1006 GMT - AstraZeneca is among the most mentioned companies
across news items over the past six hours, according to Factiva
data, after the company posted a higher first-quarter profit which
beat analysts' expectations. The Anglo-Swedish pharma giant also
backed its guidance for the full year, saying that it expects total
revenue to increase by a low-to-mid single-digit percentage.
Excluding Covid-19 medicines, total revenue is expected to increase
by a low double-digit percentage, and core EPS is expected to
increase by a high single-digit to low double-digit percentage,
AstraZeneca said. Net profit for the quarter came in at $1.80
billion, up from $388 million the year prior, and beating analysts'
expectations of $1.52 billion. Revenue, however, was hurt by a
decline of $1.46 billion in sales of Covid-19 medicines, and came
in at $10.88 billion from $11.39 billion in the same quarter of
2022, the company said. Dow Jones & Co. owns Factiva.
(cecilia.butini@wsj.com)
(END) Dow Jones Newswires
April 27, 2023 06:21 ET (10:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024